Synaptogenix Inc (SNPX)

[InTheTrenches]

I agree coach/antti. There will be a lot of buzz if NTRP is successful in this readout.

If NTRP repeats previous p2 subgroup results:

There are several historical stock comparisons that put NTRP market cap anywhere in the $750M-$2.2B range over the next few years. Any comparisons are many multiples of where we are today.

It will be the first double-blind, placebo-controlled trial that shows reversal of Alzheimer's Disease. And all competitors are at least a few years away from similar results in AD.

Certainly that is worth a higher market cap range, especially if the p-value blows away past Alzheimer's trials (p=.01 or better), as antti points out.

And while we wait for P3, I'm sure progress will be made in other CNS diseases (Fragile-X, MS, etc), and earlier stage Alzheimer's (mild-to-moderate), and synthetic formulation, and an oral version of Bryostatin.

A lot to look forward to, if we succeed in P2 results in 3-4 months!